The syringe and needle segment is experiencing different growth trends. The Europe market for syringes and needles is expected to reach over €675 million by 2023 due to a strong shift towards the use of more expensive safety needles.

1. BECTON DICKINSON, B. BRAUN
LEAD EUROPEAN SYRINGE AND
NEEDLE MARKET DUE TO
CONVERSION FROM CONVENTIONAL
TO SAFETY NEEDLES
IDATA RESEARCH INC.
DECEMBER 2016
EUROPEAN MARKET REPORT SUITE FOR VASCULAR ACCESS
DEVICES AND ACCESSORIES 2017

2. IDATA RESEARCH INC.
$ 675 MILLION
BY 2023
The syringe and needle segment is
experiencing different growth trends. The
Europe market for syringes and needles is
expected to reach over €675 million by
2023 due to a strong shift towards the use
of more expensive safety needles.

3. IDATA RESEARCH INC.
PRICING
PRESSURE
The majority of syringes and needles in Europe are sold separately and
combined when used, but there are some unique markets such as Italy
where high sales of syringes and needles already attached, make the
standalone market small by comparison. Products in this market are
perceived as commodities and, as a result, the increase in average selling
price (ASP) is limited by pricing pressure.

4. IDATA RESEARCH INC.
LEADING
COMPETITORS
Becton Dickinson is the leading competitor in the European syringe and needle market. The
company produces millions of syringes and takes advantage of economies of scale to
produce and sell syringes at a lower cost than many of its competitors. This has caused the
ASP of many segments of the total market for syringes and needles to decline as companies
attempt to remain competitive. Becton Dickinson’s syringe and needle portfolio includes the
SafetyGlide™ shielding hypodermic needle, the Safety-Lok™ sliding sheath syringe, the
Eclipse™ pivoting blood collection needle and the Integra™ retractable syringe.

5. “ TOTAL SYRINGE UNIT SALES ARE
INCREASING AT A SLOWER PACE THAN
TOTAL NEEDLE SALES, DUE IN PART TO THE
DECLINING UNIT SALES OF INSULIN
SYRINGES, WHICH ARE INCORPORATED
INTO THE OVERALL SYRINGE MARKET. ”
IDATA RESEARCH INC.
- - KAMRAN ZAMANIAN ( IDATA RESEARCH INC. CEO)
“ THE DECREASE IN UNIT SALES OF INSULIN SYRINGES IS
TAKING PLACE DUE TO THE SHIFT TOWARDS THE USE OF
INSULIN PEN NEEDLES. ”

6. VISIT
IDATARESEARCH. COM
FOR MORE INFORMATION
IDATA RESEARCH INC.
DECEMBER 2016
EUROPEAN MARKET REPORT SUITE FOR VASCULAR ACCESS
DEVICES AND ACCESSORIES 2017